¼¼°èÀÇ ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ±â±â À¯Çüº°, ÇØºÎÇÐÀû ºÎÀ§º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Services (Endovascular Devices, Surgical Devices), By Anatomical Site (Aortoiliac, Femoropopliteal), By End-use, By Region, And Segment Forecasts, 2025 - 2033
»óǰÄÚµå : 1790389
¸®¼­Ä¡»ç : Grand View Research
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 90 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,356,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,760,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,569,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå °³¿ä

¼¼°è ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå ±Ô¸ð´Â 2024³â 73¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2033³â¿¡´Â 113¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â ¿¬Æò±Õ 5.2% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áúº´ ºÎ´ã Áõ°¡, Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü, Àα¸ °í·ÉÈ­¶ó´Â º¹ÇÕÀûÀÎ ¿äÀÎÀÌ ¸»Ãʵ¿¸ÆÁúȯ(PAD) »ê¾÷À» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ÃæÁ·µÇÁö ¾ÊÀº ÀÓ»óÀû ¿ä±¸¿Í ÁøÈ­ÇÏ´Â Ä¡·á ´É·ÂÀÌ ¸¸³ª¸é¼­ ÀÇ·á ÇöÀå Àü¹Ý ¼ö¿ä°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´°ú ´ã¹èÀÇ À¯º´·ü Áõ°¡´Â ¿©ÀüÈ÷ ½ÃÀåÀ» À̲ô´Â ±âº» µ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. µÎ À§ÇèÀÎÀÚ ¸ðµÎ PADÀÇ ÇÙ½É º´¸®ÇÐÀû ±âÀüÀÎ Á׻󵿸ưæÈ­ÁõÀÇ ÁøÇà¿¡ Á÷Á¢ÀûÀ¸·Î ±â¿©ÇÕ´Ï´Ù. ´ç´¢º´ À¯º´·üÀº Àü ¼¼°èÀûÀ¸·Î Áõ°¡ Ãß¼¼¿¡ ÀÖÀ¸¸ç, ƯÈ÷ µµ½Ã °í·ÉÈ­ »çȸ¿¡¼­ µÎµå·¯Áö°í, Àú¼Òµæ ±¹°¡¿¡¼­´Â Èí¿¬ÀÌ ¿©ÀüÈ÷ ¸¸¿¬ÇØ Àֱ⠶§¹®¿¡ PADÀÇ À¯º´·üÀº °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

2025³â 3¿ù ACC ÇÐȸ¿¡¼­ ¹ßÇ¥µÈ Intermountain HealthÀÇ ¿¬±¸¿¡ µû¸£¸é, Áõ»óÀÌ ÀÖ´Â ¸»Ãʵ¿¸ÆÁúȯ ȯÀÚ Áß °¡À̵å¶óÀο¡ µû¸¥ Ä¡·á¸¦ ¹ÞÀº ȯÀÚ´Â ¿©¼º 29.6%, ³²¼º 33.5%¿¡ ºÒ°úÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÃßÀûÇÑ 7,522¸íÀÇ È¯ÀÚ Áß »ç¸Á·üÀÌ 50%¸¦ ³Ñ¾î Áø´Ü°ú Ä¡·áÀÇ ½É°¢ÇÑ °ÝÂ÷¸¦ µå·¯³Â½À´Ï´Ù. ºñ½ÁÇÑ ¹ßÇ¥À²¿¡µµ ºÒ±¸Çϰí, ¿©¼ºÀº ÃÖÀûÀÇ Ä¡·á¸¦ ¹ÞÀ» °¡´É¼ºÀÌ ³·¾Ò½À´Ï´Ù. ÀÌ ¿¬±¸´Â ½ºÅ©¸®´× ÇÁ·ÎÅäÄÝÀÇ °³¼±°ú PAD °ü¸®¿¡ ´ëÇÑ °­Á¶ÀÇ Çʿ伺À» °­Á¶Çß½À´Ï´Ù.

Ç÷°ü ³» Ä¡·á ±â¼úÀÇ ±Þ¼ÓÇÑ Çõ½ÅÀº Ä¡·á Àü·«À» À籸¼ºÇÏ°í ½ÃÀåÀÇ ¸ð¸àÅÒÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¾à¹° ÄÚÆÃ Ç³¼±, µ¿¸ÆÀýÁ¦¼ú ½Ã½ºÅÛ, »ýü Èí¼ö¼º ½ºÅÙÆ® µî Â÷¼¼´ë µµ±¸´Â È¿°ú Çâ»ó, ÇÕº´Áõ °¨¼Ò, ȸº¹ ½Ã°£ ´ÜÃàÀ» °¡Á®¿É´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº º¹ÀâÇÑ º´º¯À» Á¤È®ÇÏ°Ô Ä¡·áÇÏ´Â µ¿½Ã¿¡ ÀçÇùÂøÀ̳ª Àç¼ö¼úÀÇ Çʿ伺À» ÁÙÀ̱â À§ÇØ Á¡Á¡ ´õ ¸¹ÀÌ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. 2025³â 3¿ù, Scientific Reports¿¡ °ÔÀçµÈ ¿¬±¸¿¡¼­´Â Ç÷°ü ³» Ä¡·á Áß ½ºÅÙÆ® »ðÀÔ Á¤È®µµ¸¦ Çâ»ó½ÃŰ´Â µö·¯´× ¸ðµ¨ DBMedDetÀÌ ¹ßÇ¥µÇ¾ú½À´Ï´Ù. ³ôÀº Á¤È®µµ(MAP 0.841)¿Í ½Ç½Ã°£ °ËÃâ(127 FPS)·Î °ü»óµ¿¸Æ, ¸»ÃÊÇ÷°ü, ³úÇ÷°ü °¢ »ç·Ê¿¡¼­ ½ºÅÙÆ® °æ°è¸¦ ½Äº°ÇÏ´Â µ¥ ÀÖ¾î YOLO ¸ðµ¨À» ´É°¡ÇÏ´Â °á°ú¸¦ º¸¿´½À´Ï´Ù.

Àα¸ÀÇ °í·ÉÈ­´Â PAD ÁßÀç¼ú ½ÃÀå ÀáÀç·ÂÀ» ´õ¿í ÁõÆø½Ã۰í ÀÖÀ¸¸ç, 65¼¼ ÀÌ»óÀº ÇöÀúÈ÷ ³ôÀº À§Çè¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ³ëÈ­¿Í °ü·ÃµÈ µ¿¸Æ°æÈ­ ¹× µ¿¹Ý ÁúȯÀÇ ÃàÀûÀº ÀÌ Àα¸ Áý´ÜÀ» ƯÈ÷ Ãë¾àÇÏ°Ô ¸¸µì´Ï´Ù. 2025³â 3¿ù, ¿¡ÀÌ¡ Àú³Î(Aging Journal)Àº Long Life Family StudyÀÇ °á°ú¸¦ ¹ßÇ¥Çߴµ¥, Àå¼ö °¡Á·Àº PADÀÇ À§ÇèÀÌ ÇöÀúÈ÷ ³·´Ù´Â °ÍÀ» º¸¿©ÁÖ¾ú½À´Ï´Ù. ÀÌµé °¡¹®ÀÇ ÀÚ¼ÕÀÇ PAD À¯º´·üÀº ¿¹»óÄ¡ÀÎ 12% ´ëºñ 1%¿¡ ºÒ°úÇß½À´Ï´Ù. ¿¬±¸ÆÀÀº ÀÌ °á°ú¸¦ º¸È£ À¯ÀüÇüÁú°ú °Ç°­ÇÑ Ç÷°ü ÇÁ·ÎÆÄÀϰú ¿¬°áÇÏ¿© PAD ÀúÇ×¼º°ú °ü·ÃÀÌ ÀÖÀ» ¼ö ÀÖ´Â 4°³ÀÇ À¯Àüü ¿µ¿ªÀ» È®ÀÎÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§

Á¦4Àå ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå : ±â±â À¯Çüº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦5Àå ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå : ÇØºÎÇÐÀû ºÎÀ§º°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦6Àå ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå : ±¹, ±â±â À¯Çü, ÇØºÎÇÐÀû ºÎÀ§, ÃÖÁ¾ ¿ëµµ¿¡ ÀÇÇÑ Áö¿ªº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Peripheral Artery Disease Market Summary

The global peripheral artery disease market size was estimated at USD 7.3 billion in 2024 and is projected to reach USD 11.3 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The intersecting forces of rising disease burden, continuous technological advancement, and demographic aging drive the peripheral artery disease (PAD) industry.

This alignment of unmet clinical needs with evolving therapeutic capabilities accelerates demand across care settings. The growing prevalence of diabetes and tobacco use remains a foundational force driving the market. Both risk factors contribute directly to the progression of atherosclerosis, the core pathological mechanism behind PAD. With diabetes rates climbing globally-particularly in aging, urban populations-and smoking still widespread in lower-income countries, the incidence of PAD continues to rise.

In March 2025, an Intermountain Health study presented at the ACC conference revealed that only 29.6% of women and 33.5% of men with symptomatic peripheral artery disease received full guideline-directed therapy. Among 7,522 patients tracked, the mortality rate exceeded 50%, underscoring severe gaps in diagnosis and treatment. Despite similar referral rates, women were less likely to receive optimal care. The study emphasized the need for improved screening protocols and focused PAD management.

Rapid innovation in endovascular technologies is reshaping treatment strategies and reinforcing market momentum. Next-generation tools such as drug-coated balloons, atherectomy systems, and bioresorbable stents offer improved efficacy, fewer complications, and shorter recovery times. These solutions are increasingly favored for treating complex lesions precisely while reducing restenosis and the need for repeat interventions. In March 2025, a study in Scientific Reports introduced DBMedDet, a deep-learning model that improved stent placement accuracy during endovascular procedures. With high precision (mAP 0.841) and real-time detection (127 FPS), it outperformed YOLO models in identifying stent boundaries across coronary, peripheral, and cerebrovascular cases.

Population aging further amplifies the market potential for PAD interventions, with individuals over 65 facing significantly elevated risk. Age-related arterial stiffening and the accumulation of comorbidities make this demographic especially vulnerable. In March 2025, the Aging Journal published findings from the Long Life Family Study showing individuals from long-lived families have a significantly lower risk of PAD. PAD prevalence among offspring of these families was only 1%, versus an expected 12%. Researchers linked this to protective genetic traits and healthier vascular profiles, identifying four genomic regions potentially tied to PAD resistance.

Global Peripheral Artery Disease Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global peripheral artery disease market report based on device type, anatomical site, end use, and region:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Global Peripheral Artery Disease Market Variables, Trends & Scope

Chapter 4. Peripheral Artery Disease Market: Device Type Estimates & Trend Analysis

Chapter 5. Peripheral Artery Disease Market: Anatomical Site Estimates & Trend Analysis

Chapter 6. Peripheral Artery Disease Market: End Use Estimates & Trend Analysis

Chapter 7. Peripheral Artery Disease Market: Regional Estimates & Trend Analysis by Country, Device Type, Anatomical Site & End Use

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â